HYPMY Hypera S.A. Sponsored ADR
- 5.287
- -0.264-4.75%
Hypera S.A. Sponsored ADR News
Hypera S.A. Sponsored ADR To Go Ex-Dividend On May 2nd, 2024 With 0.01898 USD Special Dividend Per Share
April 27th - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on May 2nd, 2024. Shareholders of record on May 3rd, 2024 will receive 0.01898 USD special dividend per share. The ex-divi
Hypera SA's Dividend Analysis
Hypera S.A. Sponsored ADR To Go Ex-Dividend On March 22nd, 2024 With 0.01947 USD Special Dividend Per Share
March 20th - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on March 22nd, 2024. Shareholders of record on March 25th, 2024 will receive 0.01947 USD special dividend per share. The e
Hypera S.A. Sponsored ADR To Go Ex-Dividend On March 1st, 2024 With 0.01973 USD Special Dividend Per Share
February 24th - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on March 1st, 2024. Shareholders of record on March 4th, 2024 will receive 0.01973 USD special dividend per share. The
Hypera S.A. Goes Ex Dividend Tomorrow
Hypera S.A. Sponsored ADR To Go Ex-Dividend On February 8th, 2024 With 0.01958 USD Special Dividend Per Share
February 2nd - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on February 8th, 2024. Shareholders of record on February 9th, 2024 will receive 0.01958 USD special dividend per share.
Hypera S.A. Sponsored ADR To Go Ex-Dividend On December 28th, 2023 With 0.06276 USD Special Dividend Per Share
December 20th - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on December 28th, 2023. Shareholders of record on December 29th, 2023 will receive 0.06276 USD special dividend per sha
Hypera Sees Weak Sales As Transitory -- Market Talk
0842 ET - Hypera management expects the Brazilian pharmaceutical's weak 3Q sales to be a temporary situation, say Citi Research analysts Leandro Bastos and Renan Prata in a research note. Citi trimmed
Hypera Shares Fall 7.2% After Soft 3Q Earnings
By Jeffrey T. Lewis SÃO PAULO--Hypera shares fell 7.2% after the Brazilian pharmaceuticals company reported third-quarter earnings affected by softer sales of flu medicines. Shares reached 31.72 re
Hypera Maintained Cash Generation Amid Tough 3Q -- Market Talk
0901 ET - Hypera's 3Q sales of anti-flu medicines were hit by warm winter weather that reduced demand, but the Brazilian pharmaceutical company was able to maintain high cash generation, say XP Invest
Hypera Sales Seen Weaker On Reduced Discounts -- Market Talk
0830 ET - Hypera's 2023 sales guidance faces some downside risks after the Brazilian pharmaceuticals company chose to reduce some discounts and after demand from consumers has been weaker then expecte
Hypera S.A. Sponsored ADR To Go Ex-Dividend On October 5th, 2023 With 0.062 USD Special Dividend Per Share
September 28th - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on October 5th, 2023. Shareholders of record on October 6th, 2023 will receive 0.062 USD special dividend per share. T
Hypera Goes Ex-dividend Tomorrow
Hypera S.A. Sponsored ADR To Go Ex-Dividend On July 6th, 2023 With 0.06409 USD Special Dividend Per Share
June 30th - $Hypera S.A. Sponsored ADR(HYPMY.US)$ is trading ex-dividend on July 6th, 2023. Shareholders of record on July 7th, 2023 will receive 0.06409 USD special dividend per share. The ex-div
Pacific Shuanglin Bio-pharmacy Signs Drug Supply, Distribution Deal With Brazil's Hypera Pharma
12:06 AM EDT, 05/05/2023 (MT Newswires) -- Pacific Shuanglin Bio-pharmacy (SHE:000403) has struck a drug supply and distribution agreement with Brazilian drug producer and distributor Hypera Pharma, a
Analyzing Elanco Animal Health (NYSE:ELAN) & Hypera (OTCMKTS:HYPMY)
Elanco Animal Health (NYSE:ELAN – Get Rating) and Hypera (OTCMKTS:HYPMY – Get Rating) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on
Clever Leaves Teams Up With Hypera Pharma for Brazil Expansion Project
04:10 PM EDT, 04/18/2023 (MT Newswires) -- Clever Leaves Holdings (CLVR) said Tuesday it has signed a five-year agreement with Brazilian pharmaceutical company Hypera Pharma to supply Clever Leaves' C
Clever Leaves Enters Into 5-Year Agreement With Hypera Pharma To Supply Co's CBD-Dominant Oral Solutions
Clever Leaves Enters Into 5-Year Agreement With Hypera Pharma To Supply Co's CBD-Dominant Oral Solutions
Clever Leaves Expands Presence in Brazil Through Partnership With Hypera Pharma
Hypera (OTCMKTS:HYPMY) Stock Passes Below 50-Day Moving Average of $8.10
Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $8.10 and traded as low as $7.
Analysis
Price Target
No Data
